Silverarc Capital Management, LLC has filed its 13F form on May 14, 2024 for Q1 2024 where it was disclosed a total value porftolio of $298 Million distributed in 77 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $25.5M, Morphic Holding, Inc. with a value of $17M, Oric Pharmaceuticals, Inc. with a value of $15.3M, Mersana Therapeutics, Inc. with a value of $13.3M, and Celldex Therapeutics, Inc. with a value of $12.6M.

Examining the 13F form we can see an decrease of $18.5M in the current position value, from $316M to 298M.

Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $298 Million
Healthcare: $298 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 77
  • Current Value $298 Million
  • Prior Value $316 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 14, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 30 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.